are specifically quantitated (ultraviolet detection at 313 nm) with an octadecyl silane reversed-phase chromatographic column by peak-height determination or by peak-height ratios (internal standard, o-methoxybenzoic acid). Sample preparation requires addition of an equal volume of methyl cyanide (with or without the internal standard) to precipitate proteins. After centrifugation, an aliquot of the supernate is directly injected onto the column. Salicylic acid and metabolites are eluted with a mixture of methanol and dilute acetic acid. Sensitivity is 20 ig/L, with linear response to at least 2000 mg/L for salicylic acid and its metabolites. Analytical recovery of salicylic acid and metabolites from plasma is complete. Intra-assay precision (CV) is 2.94% at 8.11 mg/L for salicylic acid; 4.10% at 7.95 mg/L for salicyluric acid; and 3.10% at 7.94 mg/L for gentisic acid. Interassay precision is 2.70% at 8.87 mg/L for salicylic acid; 4.47% at 9.02 mg/L for salicyluric acid; and 4.24% at 8.75 mg/L for gentisic acid. We saw no interference in sara from patients being treated with various drugs other than aspirin. This method estimates salicylic acid and metabolites within 12 mm; the limit of detection is 3 ng. Under normal laboratory conditions microorganisms can drastically alter salicyluric acid and salicylic acid concentrations, leading to erroneous results. Treatment of samples with sodium azide overcomes this problem. We estimated gentisic acid, salicyluric acid, and salicylic acid in plasma from a human volunteer after a single 21 mg/kg oral dose of aspirin. Methods for determination of SA itself or one or more of its metabolites, or both, include: gas-liquid chromatography (9) (10) (11) (12) (13) (14) (15) , thin-layer chromatography (16, 17) , spectrofluorometry (18, 19) , and colorimetry (3, (20) (21) (22) . Much valuable pharmacokinetic data has been accumulated by these methods, mainly in the assay of urine containing SA and its metabolites. Some high-performance liquid-chromatographic assays for ASA, SUA, and SA have recently been developed that require solvent extractions before analyses, but there were no studies of samples containing concomitantly administered drugs, to demonstrate the specificity of the assays In the present method we use a microparticulate chemically-bonded column packing to rapidly separate and quantitate SA, SUA, and GA in plasma by means of reversed-phase partitioning with a high-performance liquid chromatograph.
The observation that microorganisms can drastically change the concentrations of SUA and SA in samples at room temperature is also examined.
Materials and Methods

Materials
Chemicals:
SA, GA (2,4-dihydroxybenzoic acid), and omethoxybenzoic acid (o-anisic acid) were purchased from Eastman Organic Chemicals; SUA (o-hydroxyhippuric acid) from Sigma Chemical Co.; and methyl cyanide (acetonitrile), sodium azide, glacial acetic acid, and methanol from Ajax Chemicals. All chemicals were AR grade and were used without further treatment except for methanol, which was glass-distilled once.
Instrumentation:
We used a Model 6000 A Solvent Delivery System, Model U6K Universal Injector, Model 660 Solvent Programmer and Model 440 Absorbance Detector (all from Waters Associates, Inc., Milford, MA 01757).
The prepacked column was a 30 cm X 3.9 mm "tBondapak C,8 (ODS)", average particle size 10 tm (Waters Associates, Inc.). Peak heights at 313 nm were recorded with a 10-mV potentiometric dual-channel chart recorder (Waters Associates, Inc.). All separations were done at ambient temperature.
Mobile phase: One eluent constituent, solvent A, consisted of a mixture of glacial acetic acid and water (5/95 by vol). The other eluent constituent, solvent B, consisted of pure methanol. These solvents were filtered through a glass filter (pore size, 0.5 tim; Millipore Corp., Bedford, MA 01730) and then degassed under reduced pressure. The solvent programmer was set to let the pumps deliver an 82/18 (by vol) mixture of solvents A and B. If only one pump is available, an isocratic system consisting of a single eluent containing acetic acid! methanol/water (41/180/779 by vol) may be used. The flow rate was 2.6 mL/min.
Preparation of Standard Curves
Plasma was obtained from the blood bank. De-ionized water and plasma found to have no detectable salicylates by this present method were used to make up solutions ranging in concentration from 0.2 to 2000 mg of SA, SUA, and GA per liter.
Aliquots of the standard solutions were added to an equal volume of methyl cyanide containing 20 mg of the internal standard, o-methoxybenzoic acid, per liter to produce a onephase solution in 10 X 70 mm disposable culture tubes. The samples were mixed on a vortex-type mixer for 1 mm, centrifuged at 900 X g for 10 mm,and 20 1zLof the supernate was directly injected into the column. Standard curves were constructed from data on both absolute peak-heights and peakheight ratios of metabolite to internal standard. De-ionized water and plasma blanks were analyzed with each set of standards.
Plasma samples from salicylate-treated patients were deproteinized and chromatographed in the same manner.
Peak Identification SA, SUA, and GA were identified on the basis of their retention times, co-chromatography with the internal standard, absorbance ratios at different wavelengths, and addition of standards to test samples. Absorbance ratios at two wavelengths were sometimes used for on-line identification of SA, SUA, and GA and determination of peak purity.
Some Analytical Variables
Linearity of response with absorbance scale: A standard concentration of SA in water was applied to the column and the absorbance was determined in the absorbance ranges 0.005, 0.01, 0.02, and 0.05.
Linearity of response with injection
volume: Various volumes (5 to 1000 tL) of a standard concentration of SA were applied to the column and the corresponding absorbances determined.
Effect of extraction time: Known amounts of SA, SUA, and GA were added to plasma and extracted with an equal volume of methyl cyanide by vortex-mixing for various intervals. Analytical recovery studies:
Three batches of pooled plasma from subjects who were being treated with aspirin were used for this study. The concentrations of SA, SUA, and GA in the pooled plasma were determined. Known amounts of these components in standard solutions were added to isotonic saline and to the pooled plasma. The preparations were then analyzed for their SA, SUA, and GA contents, and the recoveries of the exogeneous components were calculated.
Intra-and inter-assay reproducibility:
Pooled samples of human plasma with known concentrations of SA, SUA, and GA were used for these studies, which extended over one month.
Specificity:
Specificity of the method was studied by assaying plasma samples from patients receiving various commonly used drugs other than salicylates, and by examining plasma samples to which pure drugs had been added.
Treatment of sample specimens:
During the course of our investigation we observed that the concentrations of SUA in Table 1 illustrates the linearity of the calibration curves for GA, SUA, and SA concentrations in plasma ranging from 0.5 to 205 mg/L. The response factors (peak height ratio/weight ratio) were fairly constant for the drugs at the given concentrations, indicating good linearity. No significant differences were observed between standards made up in water and plasma. The regression equations obtained from data on standards in water, when peak-height ratios were taken, were: for GA, y = 0. 188x -0.04 1, r = 0.9998; for SUA, (Table 1) . Thus estimations of SA, SUA, and GA are accurate whether absolute peak height measurements or peak height ratios are used.
When the absorbance of a standard solution of SA was read on the various absorbance ranges a constant value was obtained. Thus the response of the absorbance scale was linear. Varying the injection volumes from 5 to 1000 ML of a standard concentration of SA produced a linear increase in absorbance.
The plasma was deproteinized and the salicylates released within 1 mm of vortex-mixing, and all the salicylates were in the final single-phase supernate.
Absolute recoveries of SA (200 to 300 mg/L) ranged from 99 to 102%,of GA (3 to 15 mg/L) from 99 to 102%, and of SUA (8 to 24 mg/L) from 98 to 104%. Table 2 shows the results of our studies of precision.
Interference by other drugs was studied with use both of solutions of the drug and of samples from patients taking the medications listed in (Table 3) . Methyclothiazide was incompletely resolved from SA. The therapeutic range of this drug is unknown, but plasma sampled from subjects at various periods after oral intake of a 5-mg dose of methyclothiazide (recommended dose 2.5-5 mg), when assayed by the described method, resulted in a maximum overestimate of SA of 1 mg/L.
None of the other drugs listed in Table 3 showed any interference. 5.5 to 8 neither promoted or inhibited this occurrence. When sodium azide was added to the samples (100 mg/L final concentration) SUA was stable in solution at room temperature and was not converted to SA, but the pH of the solution exceeded 8. At this pH GA is unstable and was probably oxidized. Hence erroneous results would be obtained for GA. These problems were overcome by using a stock solution of sodium azide that had been adjusted to pH 7.4 with acetic acid, and adding it both to standard solutions and samples.
The proposed method was applied to measure GA, SUA, and SA in plasma after a single oral 21 mg/kg dose of ASA ( Figure 4 ).
DiscussIon
Our method specifically separates and quantitates GA, SUA, and SA accurately and rapidly; sample preparation by deproteinization with methyl cyanide simplifies and speeds the assay. Each assay requires about 15 mm from receipt of the plasma sample. Because only 20 ILL of the supernate is injected and chromatographed, as little as 20 ML of plasma can be assayed, an advantage in monitoring pediatric patients.
The surface of the column packing in this study is essentially a C18 hydrocarbon. For components to be separated on this column, they must possesssome non-polar characteristics. We chose to use a wavelength (313 nm) in the absorption band closest to the visible region. This band is not the most intense of those for the salicylates, but we regard it as the peak of choice because it is much more specific for these compounds; it proved to be the optimal wavelength under clinical conditions.
Although the molar absorptivity coefficients of the separated components are not maximal at this wavelength,5 they were adequate to enable estimation of the components in concentrations on the order of 20 g/L. We estimated SA, SUA, and GA by a highly specific method. Our assayis an improvement over other methods for measuring these drugs in clinical samples. it is more specific than colorimetric and spectrofluoroznetric methods, particularly those in which the drug is no4 separated from interfering substances by extraction. Gas-chromatographic methods involve derivatization of the drugs, withitsaccompanying difficulties. Recently, two liquid-chreanatographic methods have been published for salicylates in plasmL Peng eta!. Our study indicates that microorganisms can affect the concentrations of both SUA and SA. We advise that sodium azide at pH 7.4 be added promptly to specimens and standard solutions.
Our method is currently being used for pharmacokinetic studies of SA, SUA, and GA in patients.
